In Bacterial infections Kumagyl T 300mg/250mg Tablet stops the growth of infectious bacteria and helps treat infections caused by bacteria. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant. Drink plenty of fluids while taking it to make sure you stay hydrated.
Consuming alcohol while taking Kumagyl T 300mg/250mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Kumagyl T 300mg/250mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life
Breast feeding : SAFE IF PRESCRIBED
term because milk levels are low. Prolonged or repeated use may cause staining of babies dental enamel or bone deposition of Kumagyl T 300mg/250mg Tablet.
Kumagyl T 300mg/250mg Tablet may cause side effects which could affect your ability to drive. Kumagyl T 300mg/250mg Tablet may make you feel sleepy, dizzy, confused. You may have hallucinations, fits (convulsions) or temporary eyesight problems (such as blurred or double vision) affecting your ability to drive.
Kumagyl T 300mg/250mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Kumagyl T 300mg/250mg Tablet may be needed. Please consult your doctor. Use of Kumagyl T 300mg/250mg Tablet is not recommended in patients with severe kidney disease.
Kumagyl T 300mg/250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Kumagyl T 300mg/250mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Kumagyl T 300mg/250mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More